{"nct_id":"NCT00385580","title":"Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer","status":"COMPLETED","status_verified_date":"2012-10","start_date":"2007-01","start_date_type":null,"primary_completion_date":"2008-12","primary_completion_date_type":"ACTUAL","completion_date":"2010-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}